8-K: AdaptHealth Stockholders Elect Directors, Ratify Auditor, and Approve Executive Compensation at Annual Meeting
Annual Meeting Results
AdaptHealth Corp. announced that its stockholders approved all three proposals at the annual meeting held on June 18, 2025, including the election of six directors, the ratification of KPMG LLP as its independent auditor, and the advisory approval of executive compensation.
Summary
- AdaptHealth Corp. held its annual meeting of stockholders on June 18, 2025, via live audio webcast.
- A quorum was present with 126,498,289 shares, representing 93.32% of the voting power, present or represented by proxy.
- Stockholders elected six directors for a one-year term: Terence Connors, Brad Coppens, Ted Lundberg, Dr. Susan Weaver, David Williams III, and Dale Wolf.
- The appointment of KPMG LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified with 124,299,342 votes for, 2,086,471 against, and 112,476 abstentions.
- A non-binding advisory vote to approve the compensation paid to named executive officers was approved with 105,733,612 votes for, 6,409,613 against, 40,368 abstentions, and 14,314,696 broker non-votes.
Sentiment
Score: 7
Explanation: The sentiment is generally positive as all proposals, including the election of directors, ratification of the auditor, and advisory approval of executive compensation, were approved by stockholders. The high quorum also indicates strong shareholder engagement. However, the notable number of "withheld" votes for some director nominees introduces a slight element of dissent, preventing a top-tier positive score.
Positives
- All three proposals presented at the Annual Meeting were approved by stockholders.
- The election of all six director nominees ensures continuity in the board's composition.
- The ratification of KPMG LLP provides stability in the company's auditing oversight for the fiscal year ending December 31, 2025.
- The advisory approval of executive compensation indicates general stockholder support for the current compensation structure.
- A high quorum of 93.32% of voting power indicates strong stockholder engagement and participation.
Negatives
- While elected, some director nominees (Terence Connors, Brad Coppens, Ted Lundberg, Dale Wolf) received a significant number of "Withheld" votes, indicating some level of dissent or lack of full support from a portion of the voting shareholders. For example, Terence Connors had 40,867,177 "Withheld" votes against 71,316,416 "For" votes.
Future Outlook
The document does not contain explicit forward-looking statements or guidance beyond the term of the elected directors (until the 2026 annual meeting) and the fiscal year for which the auditor was ratified (ending December 31, 2025).
Industry Context
This filing is a standard disclosure of annual meeting voting results, common across publicly traded companies. It reflects routine corporate governance practices within the healthcare services industry, specifically for a company like AdaptHealth Corp. which provides home medical equipment and supplies. The successful passage of all proposals indicates a stable governance environment, which is generally viewed positively in the healthcare sector, where regulatory compliance and operational stability are crucial.
Comparison to Industry Standards
- The quorum of 93.32% is exceptionally high, indicating strong shareholder engagement and participation, which is generally above average for public companies.
- The election of all director nominees and ratification of the auditor are standard outcomes for most well-governed public companies.
- The advisory approval of executive compensation, while non-binding, is also a common practice and its approval aligns with typical industry outcomes, though the level of "against" votes (6.4 million) could be compared to peers if specific data were available.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Election Outcome | Stockholders elected six directors for a one-year term: Terence Connors, Brad Coppens, Ted Lundberg, Dr. Susan Weaver, David Williams III, and Dale Wolf. | 2025-06-18 | Ensures continuity of board leadership for the upcoming year. |
| Auditor Ratification | Stockholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. | 2025-06-18 | Maintains stability and independence in financial auditing oversight. |
| Executive Compensation Approval (Advisory) | Stockholders approved, on a non-binding advisory basis, the compensation paid to the company's named executive officers. | 2025-06-18 | Provides management with an indication of stockholder sentiment regarding executive pay practices. |
Stakeholder Impact
- Shareholders: The approval of all proposals, including director elections and auditor ratification, provides stability and continuity in governance, which is generally positive for shareholder confidence. The advisory approval of executive compensation indicates alignment, though some "withheld" votes suggest areas for potential future engagement.
- Management/Executives: The advisory approval of executive compensation validates the current pay structure, while the election of directors provides a clear mandate for the board.
- Employees: No direct impact mentioned, but stable governance can contribute to a stable work environment.
- Auditors (KPMG LLP): Their appointment was ratified, confirming their role for the upcoming fiscal year.
Next Steps
- The elected directors will serve until the company's annual meeting of stockholders in 2026.
- KPMG LLP will serve as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
Key Dates
| Date | Description |
|---|---|
| 2025-04-24 | Record date for the Annual Meeting, determining stockholders entitled to vote. |
| 2025-04-30 | Date AdaptHealth Corp. filed its definitive proxy statement for the Annual Meeting with the SEC. |
| 2025-06-18 | Date of the Annual Meeting of stockholders where proposals were voted upon. |
| 2025-06-20 | Date the 8-K report was signed by AdaptHealth Corp. |
| 2025-12-31 | End of the fiscal year for which KPMG LLP was ratified as the independent registered public accounting firm. |
| 2026 | Year until which the elected directors will serve, or until their successors are elected. |
Recommendation
holdKeywords
AdaptHealth Corp., AHCO, SEC filing, 8-K, annual meeting, stockholder vote, director election, corporate governance, KPMG LLP, auditor ratification, executive compensation, proxy statement
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.